BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

HIVE Digital Technologies is scaling its footprint in the Bitcoin mining space, aiming to capture 2% of the global Bitcoin supply while leveraging deregulation and institutional adoption trends.

Mulvihill’s Split Preferred Share ETF offers investors a dependable monthly income stream, making it Canada’s highest-yielding preferred share ETF.